JENSEN SOREN GADE enters ALLARITY THERAPEUTICS, INC. with 2.80K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 12/22/2021ACC: 0001213900-21-067033
Director
Since Dec 2021
2.80K
Baseline shares
100% direct
2.80K
Direct ownership
1 position
26.24K
Derivative underlying
2 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock, $0.0001
DirectShares owned2.80K
Total
2.80K direct2.80K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock, $0.0001 | 2.80K | Direct |
| Total | 2.80K | 2.80K direct |
Derivative Holdings2
Stock Options
DirectUnderlying security
Common Stock
Underlying shares
25.84K
Shares owned
N/A
Exercise price
10.11
Expiration
—
Exercise window
—
Stock Options
DirectUnderlying security
Common Stock
Underlying shares
400.00
Shares owned
N/A
Exercise price
8.69
Expiration
—
Exercise window
—
Total
Underlying
26.24K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Options Direct | Common Stock | 10.11 | — | — | 25.84K | N/A |
| Stock Options Direct | Common Stock | 8.69 | — | — | 400.00 | N/A |
| Total | 26.24K | 0.00 | ||||